Stock screener
Filter the covered US universe by sector, size, profitability, dividends and performance. Every screen has its own shareable link — the address bar reflects your filters.
Showing 31–60 of 574 companies · sorted by market cap (high to low)
| Ticker | Company | Sector | Price | Market cap | P/E | Rev growth | Net margin | Div yield | 1y return |
|---|---|---|---|---|---|---|---|---|---|
| RVMD | Revolution Medicines | Health Care | $183.03 | $39.0B | n/a | n/a | -2833.9% | n/a | +378.3% |
| NTRA | Natera | Health Care | $264.22 | $37.9B | n/a | +36.6% | -9.1% | n/a | +88.8% |
| A | Agilent Technologies | Health Care | $133.46 | $37.6B | 26.6 | +9.1% | +19.6% | +0.8% | +18.6% |
| ALNY | Alnylam Pharmaceuticals | Health Care | $266.99 | $36.2B | 62.8 | +82.6% | +13.5% | n/a | -15.3% |
| WAT | Waters Corporation | Health Care | $370.82 | $35.9B | 79.8 | +26.4% | +11.9% | n/a | +29.0% |
| RPRX | Royalty Pharma | Health Care | $58.72 | $33.8B | 40.9 | +7.8% | +33.9% | +1.6% | +62.7% |
| IQV | IQVIA | Health Care | $198.52 | $33.2B | 24.0 | +7.3% | +8.3% | n/a | +26.8% |
| CNC | Centene Corporation | Health Care | $65.89 | $33.0B | n/a | +17.0% | -3.3% | n/a | +136.2% |
| ZTS | Zoetis | Health Care | $74.19 | $31.7B | 12.0 | +2.4% | +27.8% | +1.6% | -50.9% |
| BIIB | Biogen | Health Care | $197.74 | $29.8B | 21.8 | +1.2% | +13.8% | n/a | +54.7% |
| VEEV | Veeva Systems | Health Care | $184.55 | $29.8B | 31.7 | +16.3% | +28.4% | n/a | -35.3% |
| ILMN | Illumina, Inc. | Health Care | $190.87 | $29.2B | 34.2 | +1.3% | +19.4% | n/a | +87.1% |
| DXCM | Dexcom | Health Care | $71.43 | $28.8B | 31.0 | +16.1% | +19.3% | n/a | -11.0% |
| RMD | ResMed | Health Care | $192.91 | $28.2B | 18.6 | +10.3% | +27.4% | +1.2% | -27.9% |
| GEHC | GE HealthCare | Health Care | $61.41 | $27.9B | 14.6 | +6.0% | +9.1% | +0.2% | -16.3% |
| MTD | Mettler Toledo | Health Care | $1,285.90 | $26.0B | 29.7 | +6.8% | +21.4% | n/a | +5.5% |
| WST | West Pharmaceutical Services | Health Care | $358.41 | $25.8B | 47.6 | +11.2% | +16.9% | +0.3% | +63.7% |
| ROIV | Roivant Sciences | Health Care | $34.91 | $25.1B | n/a | -89.2% | -3629.2% | n/a | +203.6% |
| INSM | Insmed | Health Care | $106.64 | $23.4B | n/a | +115.1% | -144.4% | n/a | +5.7% |
| INCY | Incyte | Health Care | $115.79 | $23.3B | 16.3 | +21.5% | +26.7% | n/a | +74.2% |
| LH | Labcorp | Health Care | $281.46 | $23.1B | 24.5 | +7.3% | +6.7% | +1.0% | +11.7% |
| DGX | Quest Diagnostics | Health Care | $209.83 | $23.0B | 22.5 | +11.0% | +9.1% | +1.7% | +24.3% |
| MRNA | Moderna | Health Care | $58.07 | $22.9B | n/a | -30.0% | -143.6% | n/a | +77.4% |
| UTHR | United Therapeutics | Health Care | $527.07 | $22.7B | 17.6 | +5.9% | +40.6% | n/a | +76.9% |
| STE | Steris | Health Care | $210.57 | $20.6B | 26.3 | +8.7% | +13.2% | +1.2% | -5.9% |
| VTRS | Viatris | Health Care | $17.01 | $20.0B | n/a | +1.6% | -2.0% | +2.8% | +84.1% |
| GH | Guardant Health, Inc. | Health Care | $150.75 | $19.8B | n/a | +39.6% | -40.1% | n/a | +225.9% |
| NBIX | Neurocrine Biosciences | Health Care | $172.69 | $17.8B | 26.7 | +28.6% | +21.6% | n/a | +30.1% |
| ZBH | Zimmer Biomet | Health Care | $88.68 | $17.5B | 23.0 | +9.2% | +9.1% | +1.0% | -8.1% |
| THC | Tenet Healthcare | Health Care | $195.35 | $16.9B | 9.9 | +6.6% | +7.8% | n/a | +25.2% |
This is a shareable URL: filters live in the query string — e.g.
/browse?sector=Health+Care, /browse?index=russell2000,
/browse?mktcap=small, /browse?pe_band=under15,
/browse?growth_band=over20, /browse?margin_band=over20,
/browse?div_yield_band=over4, /browse?div_streak=ge10,
/browse?insider=cluster-buy, /browse?holder=blackrock,
/browse?short=elevated.
Combine them, sort with &sort=dividend_yield&dir=desc (or click a column
header), and page with &page=2.
Data: SEC EDGAR (filings) + Finnhub (prices, fundamentals), as of 2026-07-23 close. Prices are delayed daily-close, labelled with their as-of date.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date. Past performance does not indicate future results.